Ebola Vaccines: FDA Advisory Committee Convenes As Outbreak Recedes
This article was originally published in The Pink Sheet Daily
Executive Summary
Challenge of testing vaccines when infections seem to be coming under control is among potential issues for May 12 meeting.
You may also be interested in...
Ebola Drugs Take Center Stage In Review Voucher Bill, But Real Value May Be Harmonization
Along with adding Ebola to list of disease treatments eligible for tropical disease priority review voucher, bill moving through Congress would cut notification time required before redemption.
Ebola Treatments Could Be Orphan Candidates – But Vaccines, Probably Not
FDA expects few people would get the disease in the U.S., but many could receive a vaccine.
Gene Therapy: Pediatric Development Could Start Sooner Than Sponsors Think – FDA OTP Director
Nicole Verdun said children could participate in gene therapy clinical trials earlier if the necessary controls are in place.